These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 16425970

  • 1. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H.
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [Abstract] [Full Text] [Related]

  • 2. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH.
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
    Schug BS, Brendel E, Wonnemann M, Wolf D, Wargenau M, Dingler A, Blume HH.
    Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144
    [Abstract] [Full Text] [Related]

  • 6. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.
    Schug BS, Brendel E, Wolf D, Wonnemann M, Wargenau M, Blume HH.
    Eur J Pharm Sci; 2002 Apr; 15(3):279-85. PubMed ID: 11923060
    [Abstract] [Full Text] [Related]

  • 7. [Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets].
    Drabant S, Klebovich I, Gachályi B, Renczes G, Farsang C.
    Acta Pharm Hung; 1998 Sep; 68(5):294-306. PubMed ID: 9805816
    [Abstract] [Full Text] [Related]

  • 8. The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard).
    Armstrong J, Challenor VF, Macklin BS, Renwick AG, Waller DG.
    Eur J Clin Pharmacol; 1997 Sep; 53(2):141-3. PubMed ID: 9403286
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects.
    Lu H, Zhou F, Rui C, You H, Zhang W, Zhang Y, Ding J, Zhao S, Wu Q.
    Int J Clin Pharmacol Ther; 2024 Oct; 62(10):486-496. PubMed ID: 39078055
    [Abstract] [Full Text] [Related]

  • 10. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
    Zhang H, Wang S, Wang H, Zhi T, Ren J, Wang Y, Yao Z, Zhang P, Ye N, Zhang R.
    Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 12. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O, Alvarez JC.
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
    Xin L, Chen Q, Chen D, Li Y, Li Y, Wu Q, Zou Y, Wang W, Jia J, Yu C, Liu Y.
    Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 20. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
    Grundy JS, Foster RT.
    Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.